Dr. Reddy's Laboratories
RDY
#1726
Rank
C$16.07 B
Marketcap
C$19.22
Share price
-0.04%
Change (1 day)
-5.53%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): C$1.29 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are C$3.95 Billion. In 2024 the company made an earning of C$1.24 Billion, an increase over its 2023 earnings that were of C$1.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$1.29 B4.06%
2024 C$1.24 B7.01%
2023 C$1.16 B17.62%
2022 C$0.98 B43.27%
2021 C$0.68 B31.44%
2020 C$0.52 B54.54%
2019 C$0.33 B-14.21%
2018 C$0.39 B26.15%
2017 C$0.31 B4.69%
2016 C$0.29 B-55.7%
2015 C$0.67 B1.83%
2014 C$0.66 B-3.78%
2013 C$0.68 B54.07%
2012 C$0.44 B-16.23%
2011 C$0.53 B56.66%
2010 C$0.34 B-235.36%
2009 -C$0.26 Billion-198.53%
2008 C$0.25 B30.77%
2007 C$0.19 B-14.61%
2006 C$0.22 B703.63%
2005 C$28.5 M649.45%
2004 C$3.8 M-95.68%
2003 C$87.96 M-14.86%
2002 C$0.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$16.40 B 1,189.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.45 B 92.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$12.90 B 914.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
C$22.72 B 1,686.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$12.59 B 890.26%๐Ÿ‡ซ๐Ÿ‡ท France